Skip to main content

NovaTears®

First-in-class, preservative-free eye treatment and tear film stabilizer in evaporative dry eye disease

Our journey started with NovaTears®, the first water-free eye drop based on EyeSol® for the treatment of dry eye.

NovaTears® is CE certified since 2013 and successfully commercialized in Australia/New Zealand by AFT Pharmaceuticals and in Europe as EvoTears™ by Ursapharm.

For more details please see the current Instructions for Use.

  • As the first-of-its kind, NovaTears® offers a new Mode of Action by acting as a lubricating lipid layer stabilizer and evaporative barrier for improving tear film stability and quality.

  • NovaTears® is clinically validated by significant improvement in signs and symptoms in patients with evaporative dry eye disease and Meibomian Gland Disfunction MGD in a number of clinical trials.

Publications

more information about the clinical trials.

See More